Delivery Order SPE2DB24D3013-SPE2DB25FFQKE
- Not listed
- The Defense Logistics Agency awarded a $2,135.95 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packaging, with an ultimate completion date of August 29, 2025. This is a firm fixed price contract with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $1,645.21 and a completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp for testosterone 1% (25 mg/2.5 g) in 2.5 gram packages under a firm fixed price contract. The order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order with no small business or other...
- The Defense Logistics Agency awarded a $2,415.13 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,466.98 on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.98 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order, which utilizes no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a delivery order valued at $1,938.18 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQKEDelivery Order
The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in pharmaceutical distribution to defense and veteran healthcare systems, with previous awards covering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/25 |